Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17959415 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma
Condition: Kidney Neoplasms
Intervention: Drug: Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived Growth Factor Receptor [PDGFR] inhibitor
2 Active, not recruiting NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
Condition: Renal Cell Carcinoma
Intervention: Drug: Axitinib

Indicates status has not been verified in more than two years